Spanish-Speaking Provider for Infertility
(ImpaLa Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if Spanish-speaking patients receive better infertility care when treated by a Spanish-speaking provider rather than through an interpreter. The researchers will compare treatment progress and patient satisfaction between those who communicate directly with a Spanish-speaking doctor and those who use an interpreter. They seek Spanish-speaking individuals currently seeking fertility treatment. Participants will complete a survey to share their experiences and satisfaction. As an unphased study, this trial offers a unique opportunity to contribute to improving healthcare communication and satisfaction for Spanish-speaking patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on language and communication in fertility care, so it's unlikely that your medications will be affected.
What prior data suggests that using a Spanish-speaking provider is safe for patients?
This study is unique because it focuses on using a Spanish-speaking provider to enhance communication in fertility care. But what about safety?
In this trial, the treatment involves having a conversation in Spanish instead of using an interpreter, not a drug or procedure. Therefore, there are no physical side effects like those associated with medications. Research has shown that better communication can lead to improved healthcare outcomes. Spanish-speaking patients may feel more comfortable and understood when speaking directly with their provider, potentially leading to better overall experiences and outcomes in their treatment journey.
The study aims to determine if speaking directly with a Spanish-speaking provider helps patients navigate testing and treatment more smoothly. Since no new medical or physical treatment is being tested, there are no adverse events or side effects to consider. The focus is solely on improving communication in care.12345Why are researchers excited about this trial?
Researchers are excited about the Spanish-speaking provider approach for infertility because it directly addresses the language barrier that many Spanish-speaking patients face in healthcare. Unlike the standard practice where Spanish-speaking patients often rely on interpreters when seeing English-speaking providers, this method facilitates direct communication. This can lead to better understanding, trust, and potentially more effective and personalized care. By allowing patients to communicate in their native language, researchers hope to improve patient satisfaction and outcomes, making infertility treatments more accessible and effective for Spanish-speaking communities.
What evidence suggests that using a Spanish-speaking provider is effective for improving fertility treatment outcomes?
Research has shown that Spanish-speaking patients often achieve better treatment results when their healthcare providers also speak Spanish. This trial will compare outcomes for Spanish-speaking patients treated by Spanish-speaking providers with those treated by English-speaking providers using a qualified interpreter. Language barriers can delay treatment and hinder effective communication, negatively impacting the success of fertility treatments. Studies have found that Hispanic women often receive less infertility care and may experience worse outcomes compared to non-Hispanic White women. When patients and providers share a language, satisfaction and treatment progress can improve. Understanding the role of language in healthcare is crucial for providing fair and effective medical treatment.12367
Are You a Good Fit for This Trial?
This trial is for Spanish-speaking patients experiencing infertility who are seeking treatment at Washington University's Fertility and Reproductive Medicine Center. Participants must be comfortable completing a survey in their preferred language.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Consultation and Diagnostic Testing
Participants undergo initial consultation and complete recommended fertility diagnostic tests
Treatment
Participants receive fertility treatment based on diagnostic results
Follow-up
Participants are monitored for satisfaction and communication effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Spanish-Speaking Provider
Find a Clinic Near You
Who Is Running the Clinical Trial?
Washington University School of Medicine
Lead Sponsor